Dr. Henk van Halteren is Consultant in Medical Oncology at the Admiraal de Ruijter Hospital in the Southwest of the Netherlands.
He graduated in Internal Medicine in 2000 (University Medical Center St Radboud, Nijmegen, the Netherlands) and completed his specialist training in Medical Oncology in 2001. His thesis, finalised in 2004, dealt with different therapeutic aspects of colorectal cancer and cancer cachexia.
Until 2012, Henk van Halteren worked as a consultant in Medical Oncology in the Gelderse Vallei hospital (Ede, the Netherlands). During that period he participated with Wageningen University (division of Human Nutrition) in research on the impact of obesity on cancer behaviour. Moreover, he participated in pioneering research on chemotherapy-related bowel toxicity and changes in microbiota.
Henk van Halteren, as a team member working in a regional teaching hospital, has specialised in the treatment of urological, upper/lower GI and gynaecological malignancies, as well as breast cancer.
His department strives to participate in high quality multicentre trials.
Due to his broad spectrum of interest, Henk van Halteren has published a broad range of topics in a variety of peer - reviewed journals.